Diaminothiazoles and their use for inhibiting protein kinases
CA 2371158 A1 · Owner: Benedict, Suzanne Pritchett · Inventors: Kania, Robert Steve; Tempczyk-Russell, Anne Maria; Yang, Yi Michelle
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Diaminothiazole compounds of formula (I) that modulate and/or inhibit the activity of certain protein kinases are described. These compounds and pharmaceutical compositions containing them are capable of mediating tyrosine kinase signal transduction in order to modulate and/or inhibit unwanted cell proliferation. The invention is also directed to the therapeutic or prophylactic use of pharmaceutical compositions containing such compounds and , to methods of treating cancer as well as other disease states associated with unwanted angiogenesis and/or cellular proliferation such as diabetic , retinopathy, neovascular glaucoma rheumatoid arthritis, and psoriasis, by administering …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 2, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 2, 2020.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 2, 2022.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.